Clinical Trials Directory

Trials / Conditions / Stage IVB Hypopharyngeal Carcinoma AJCC v8

Stage IVB Hypopharyngeal Carcinoma AJCC v8

11 registered clinical trials studyying Stage IVB Hypopharyngeal Carcinoma AJCC v8 — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingComparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cann
NCT07441681
NRG OncologyPhase 3
Not Yet RecruitingTesting the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squ
NCT07156227
National Cancer Institute (NCI)Phase 1
RecruitingTesting the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy f
NCT06532279
NRG OncologyPhase 2
RecruitingComparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluati
NCT06914999
Emory UniversityEARLY_Phase 1
RecruitingTesting the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
NCT05172245
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cance
NCT04533750
National Cancer Institute (NCI)Phase 1
Active Not RecruitingCemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcin
NCT04862650
Marcelo BonomiPhase 2
CompletedSodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With
NCT04541355
Hyunseok Kang, MDPhase 2
TerminatedCelecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
NCT04162873
University of UtahPhase 2
CompletedRadiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck
NCT03258554
National Cancer Institute (NCI)Phase 2 / Phase 3
RecruitingBlood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With
NCT03010150
M.D. Anderson Cancer Center—